Therefore, in this study, we examined PD-L1 on tumor-infiltrating immune cells (TIICs) in RC specimens to investigate the prognostic role of PD-L1 on TIICs as a predictive biomarker by analyzing the correlation with tumor recurrence in “high-risk” patients after RC. This evidence concerns the gene CD274 and neoplasm.